David Grossman
Stock Analyst at Stifel
(3.66)
# 830
Out of 4,711 analysts
151
Total ratings
57.55%
Success rate
3.68%
Average return
Main Sectors:
Stocks Rated by David Grossman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Buy | $240 → $272 | $224.15 | +21.35% | 7 | Dec 6, 2024 | |
| OPRX OptimizeRx | Maintains: Buy | $13 → $8 | $4.91 | +62.93% | 6 | Nov 14, 2024 | |
| IBM International Business Machines | Maintains: Buy | $205 → $246 | $223.36 | +10.14% | 20 | Oct 16, 2024 | |
| PAYX Paychex | Maintains: Hold | $130 → $141 | $139.54 | +1.05% | 8 | Oct 2, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $16 → $9 | $9.44 | -4.66% | 10 | Aug 1, 2024 | |
| ADP Automatic Data Processing | Maintains: Hold | $271 → $287 | $294.02 | -2.39% | 10 | Aug 1, 2024 | |
| DH Definitive Healthcare | Maintains: Buy | $9.5 → $7.5 | $4.18 | +79.43% | 3 | Jul 31, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $8 | $3.48 | +129.89% | 5 | Jun 28, 2024 | |
| ACN Accenture | Maintains: Buy | $395 → $340 | $366.37 | -7.20% | 25 | Jun 12, 2024 | |
| DXC DXC Technology Company | Maintains: Hold | $21 → $19 | $20.60 | -7.77% | 10 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6.5 | $4.51 | +44.12% | 8 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $0.80 | +400.00% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $121 | $90.06 | +34.35% | 11 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $288 → $301 | $248.26 | +21.24% | 11 | Feb 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $12 | $7.09 | +69.25% | 4 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Positive | $22 → $29 | $22.73 | +27.58% | 9 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $580 | $7.87 | +7,269.76% | 1 | Dec 18, 2020 |
Veeva Systems
Dec 6, 2024
Maintains: Buy
Price Target: $240 → $272
Current: $224.15
Upside: +21.35%
OptimizeRx
Nov 14, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $4.91
Upside: +62.93%
International Business Machines
Oct 16, 2024
Maintains: Buy
Price Target: $205 → $246
Current: $223.36
Upside: +10.14%
Paychex
Oct 2, 2024
Maintains: Hold
Price Target: $130 → $141
Current: $139.54
Upside: +1.05%
Teladoc Health
Aug 1, 2024
Maintains: Hold
Price Target: $16 → $9
Current: $9.44
Upside: -4.66%
Automatic Data Processing
Aug 1, 2024
Maintains: Hold
Price Target: $271 → $287
Current: $294.02
Upside: -2.39%
Definitive Healthcare
Jul 31, 2024
Maintains: Buy
Price Target: $9.5 → $7.5
Current: $4.18
Upside: +79.43%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $3.48
Upside: +129.89%
Accenture
Jun 12, 2024
Maintains: Buy
Price Target: $395 → $340
Current: $366.37
Upside: -7.20%
DXC Technology Company
May 17, 2024
Maintains: Hold
Price Target: $21 → $19
Current: $20.60
Upside: -7.77%
Apr 30, 2024
Maintains: Buy
Price Target: $8 → $6.5
Current: $4.51
Upside: +44.12%
Apr 1, 2024
Maintains: Buy
Price Target: $4
Current: $0.80
Upside: +400.00%
Feb 16, 2024
Maintains: Buy
Price Target: $117 → $121
Current: $90.06
Upside: +34.35%
Feb 12, 2024
Maintains: Buy
Price Target: $288 → $301
Current: $248.26
Upside: +21.24%
Nov 1, 2023
Maintains: Hold
Price Target: $15 → $12
Current: $7.09
Upside: +69.25%
Jan 10, 2022
Upgrades: Positive
Price Target: $22 → $29
Current: $22.73
Upside: +27.58%
Dec 18, 2020
Initiates: Hold
Price Target: $580
Current: $7.87
Upside: +7,269.76%